Table 1 Patient's demographics
| Â | Lidocaine (n = 30) | Levo-bupivacaine (n = 30) | Placebo (n = 30) |
|---|---|---|---|
Sex (male/female) | 6/24 | 1/29 | 4/26 |
Age (year.) | 45 ± 15 | 50 ± 12 | 46 ± 13 |
Weight (kg) | 69 ± 12 | 65 ± 98 | 70 ± 17 |
Surgery HV/HV + "hammer toe" | 28/2 | 26/4 | 27/3 |
| Â | Lidocaine (n = 30) | Levo-bupivacaine (n = 30) | Placebo (n = 30) |
|---|---|---|---|
Sex (male/female) | 6/24 | 1/29 | 4/26 |
Age (year.) | 45 ± 15 | 50 ± 12 | 46 ± 13 |
Weight (kg) | 69 ± 12 | 65 ± 98 | 70 ± 17 |
Surgery HV/HV + "hammer toe" | 28/2 | 26/4 | 27/3 |
Journal of Orthopaedic Surgery and Research